SCHEMBL3206286

SCHEMBL3206286

CC1CCC(NCCc2ccccc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 6/20 0.65
TAAR1 Q96RJ0 1/20 0.59
ALDH1A1 P00352 1/20 0.59
OPRM1 P35372 1/20 0.56
OPRL1 P41146 1/20 0.56
GRIN1 Q05586 1/20 0.53
SIGMAR1 Q99720 1/20 0.53
KDM4E B2RXH2 1/20 0.52
TSHR P16473 1/20 0.52
MAPK1 P28482 1/20 0.52
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
FUCA1 P04066 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
ACHE P22303 1/20 0.49
ROCK2 O75116 1/20 0.48
ROCK1 Q13464 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3206279 1.00 GRIN2B (0.65) GRIN2BTAAR1ALDH1A1OPRM1OPRL1
SCHEMBL662411 0.91 GRIN2B (0.76) GRIN2BTAAR1OPRM1OPRL1GRIN1
SCHEMBL14117439 0.90 GRIN2B (0.67) GRIN2BALDH1A1OPRM1OPRL1GRIN1
SCHEMBL2661158 0.88 GRIN2B (0.68) GRIN2BALDH1A1OPRM1OPRL1GRIN1
SCHEMBL2661157 0.88 GRIN2B (0.68) GRIN2BALDH1A1OPRM1OPRL1GRIN1
SCHEMBL10031636 0.84 GRIN2B (0.61) GRIN2BTAAR1OPRM1OPRL1GRIN1
SCHEMBL3907332 0.83 TAAR1 (0.81) GRIN2BTAAR1ALDH1A1OPRM1OPRL1
SCHEMBL3760581 0.83 TAAR1 (0.75) GRIN2BTAAR1OPRM1OPRL1GRIN1
SCHEMBL16480070 0.83 ALDH1A1 (0.52) GRIN2BTAAR1ALDH1A1OPRM1OPRL1
SCHEMBL14934759 0.82 GRIN2B (0.65) GRIN2BTAAR1ALDH1A1OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362049-B2 Urea glucokinase activators NOVO NORDISK A/S (DK) 2013-01-29 US disclosed
US-8318778-B2 Urea glucokinase activators NOVO NORDISK A/S (DK) 2012-11-27 US disclosed
US-20120165375-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2012-06-28 US disclosed
US-20100041711-A1 Urea Glucokinase Activators NOVO NORDISK A/S (DK) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041711-A1 Urea Glucokinase Activators GCK, GCKR, HK2 GRIN2B 4168/4885TAAR1 4715/4885ALDH1A1 2703/4885
US-20120165375-A1 Urea Glucokinase Activators GCK, GCKR, HK2 GRIN2B 4168/4885TAAR1 4715/4885ALDH1A1 2703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.